Literature DB >> 8104423

Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV.

F Dabis1, P Msellati, D Dunn, P Lepage, M L Newell, C Peckham, P Van de Perre.   

Abstract

PURPOSE: In the last 8 years, numerous cohort studies have been conducted to estimate the rate of mother-to-child transmission (MTCT) of HIV. Many of these have faced problems in data collection and analysis, making it difficult to compare transmission rates between studies. This workshop on methodological aspects of the study of MTCT of HIV-1 was held in Ghent (Belgium) in February 1992. STUDY SELECTION AND DATA EXTRACTION: Fourteen teams of investigators participated, representing studies from Central (five) and Eastern Africa (three), Europe (two), Haiti (one) and the United States (three). A critical evaluation of the projects was carried out, under four headings: (1) enrollment and follow-up procedures, (2) diagnostic criteria and case definitions, (3) measurement and comparison of MTCT rates and (4) determinants of transmission. RESULTS OF DATA ANALYSIS: Reported transmission rates ranged from 13 to 32% in industrialized countries and from 25 to 48% in developing countries. However, no direct comparisons could be made because methods of calculation differed from study to study. Based on this review, a common methodology was developed. Agreement was reached on definitions of HIV-related signs/symptoms, paediatric AIDS and HIV-related deaths. A classification system of children born to HIV-1-infected mothers according to their probable HIV infection status during the first 15 months of life, allowed the elaboration of a direct method of computation of the transmission rate and of an indirect method for studies with a comparison group of children born to HIV-seronegative mothers. This standardized approach was subsequently applied to selected data sets.
CONCLUSIONS: The methodology can now be applied to all studies with sufficient follow-up and comparisons made between transmission rates. This step is essential for assessing determinants of transmission and for the development of a common approach for the evaluation of interventions aimed at reducing or interrupting MTCT of HIV.

Entities:  

Mesh:

Year:  1993        PMID: 8104423      PMCID: PMC4850214          DOI: 10.1097/00002030-199308000-00027

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  36 in total

Review 1.  Pediatric acquired immunodeficiency syndrome: special considerations for developing nations.

Authors:  T C Quinn; A Ruff; N Halsey
Journal:  Pediatr Infect Dis J       Date:  1992-07       Impact factor: 2.129

2.  Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire.

Authors:  R W Ryder; W Nsa; S E Hassig; F Behets; M Rayfield; B Ekungola; A M Nelson; U Mulenda; H Francis; K Mwandagalirwa
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

3.  Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study.

Authors:  W A Andiman; B J Simpson; B Olson; L Dember; T J Silva; G Miller
Journal:  Am J Dis Child       Date:  1990-07

4.  Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda.

Authors:  P Lepage; F Dabis; D G Hitimana; P Msellati; C Van Goethem; A M Stevens; F Nsengumuremyi; A Bazubagira; A Serufilira; A De Clercq
Journal:  AIDS       Date:  1991-03       Impact factor: 4.177

Review 5.  Perinatal human immunodeficiency virus infection: ruminations on mechanisms of transmission and methods of intervention.

Authors:  W Borkowsky; K Krasinski
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

6.  Infective and anti-infective properties of breastmilk from HIV-1-infected women.

Authors:  P Van de Perre; A Simonon; D G Hitimana; F Dabis; P Msellati; B Mukamabano; J B Butera; C Van Goethem; E Karita; P Lepage
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

Review 7.  Report of a consensus workshop, Siena, Italy, January 17-18, 1992. Early diagnosis of HIV infection in infants.

Authors: 
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Risk factors for mother-to-child transmission of HIV-1.

Authors: 
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

9.  Evaluation of a clinical case definition of AIDS in African children.

Authors:  R I Colebunders; A Greenberg; P Nguyen-Dinh; H Francis; N Kabote; L Izaley; F Davachi; T C Quinn; P Piot
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

10.  Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies.

Authors:  T C Quinn; R L Kline; N Halsey; N Hutton; A Ruff; A Butz; R Boulos; J F Modlin
Journal:  JAMA       Date:  1991-12-25       Impact factor: 56.272

View more
  11 in total

1.  Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.

Authors:  L L O'Neil; M J Burkhard; E A Hoover
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe.

Authors:  L S Zijenah; J Humphrey; K Nathoo; L Malaba; P Zvandasara; A Mahomva; P Iliff; M T Mbizvo
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

3.  Differential expression of RDC1/CXCR7 in the human placenta.

Authors:  Vishwas Tripathi; Romsha Verma; Amit Dinda; Neena Malhotra; Jagdeep Kaur; Kalpana Luthra
Journal:  J Clin Immunol       Date:  2008-10-28       Impact factor: 8.317

Review 4.  A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.

Authors:  M L Newell; D M Gibb
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

5.  Mother-to-child transmission of human immunodeficiency virus (HIV) in Ireland: a prospective study.

Authors:  C B Nourse; T Conlon; E Hayes; G Kaminski; E Griffin; I Hillary; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

6.  Retrospective study of maternal HIV-1 and HIV-2 infections and child survival in Abidjan, Côte d'Ivoire.

Authors:  K M De Cock; F Zadi; G Adjorlolo; M O Diallo; M Sassan-Morokro; E Ekpini; T Sibailly; R Doorly; V Batter; K Brattegaard
Journal:  BMJ       Date:  1994-02-12

7.  15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery.

Authors:  L Mandelbrot; P Msellati; N Meda; V Leroy; R Likikouët; P Van de Perre; L Dequae-Merchadoux; F Sylla-Koko; A Ouangre; T Ouassa; R Ramon; L Gautier-Charpentier; M Cartoux; M Dosso; F Dabis; C Welffens-Ekra
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

8.  The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women.

Authors:  A Coutsoudis; R A Bobat; H M Coovadia; L Kuhn; W Y Tsai; Z A Stein
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

Review 9.  Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.

Authors:  Andrea L Ciaranello; Ji-Eun Park; Lynn Ramirez-Avila; Kenneth A Freedberg; Rochelle P Walensky; Valeriane Leroy
Journal:  BMC Med       Date:  2011-05-20       Impact factor: 8.775

10.  RNA detection and subtype C assessment of HIV-1 in infants with diarrhea in Ethiopia.

Authors:  Workenesh Ayele; Tsehai Assefa; Sileshi Lulseged; Belete Tegbaru; Hiwot Berhanu; Wegene Tamene; Zenit Ahmedin; Birzaf W Tensai; Mengistu Tafesse; Jaap Goudsmit; Ben Berkhout; William A Paxton; Michel P Debaar; Tsehaynesh Messele; Georgios Pollakis
Journal:  Open AIDS J       Date:  2009-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.